The first lineage choice in mammalian embryogenesis is that between the trophectoderm, which gives rise to the trophoblast of the placenta, and the inner cell mass, from which is derived the embryo proper and the yolk sac. The establishment of these lineages is preceded by the inside-versus-outside positioning of cells in the early embryo and stochastic expression of key transcription factors, which is then resolved into lineage-restricted expression. The regulatory inputs that drive this restriction and how they relate to cell position are largely unknown. Here, we show an unsuspected role of Notch signaling in regulating trophectoderm-specific expression of Cdx2 in cooperation with TEAD4. Notch activity is restricted to outer cells and is able to influence positional allocation of blastomeres, mediating preferential localization to the trophectoderm. Our results show that multiple signaling inputs at preimplantation stages specify the first embryonic lineages.
INTRODUCTION
Upon fertilization, the unicellular mammalian zygote undergoes a series of equal cell divisions that in 4 days produces a 60-to 100-cell blastocyst, in which the first embryonic lineages-the trophectoderm (TE) and the inner cell mass (ICM)-have been established (Stephenson et al., 2012) . How this initial lineage choice occurs and what genetic components constitute the system that controls this process have been actively studied for the past 20 years. Key transcriptional regulators of these early lineages identified in the mammalian preimplantation embryo include OCT4, NANOG, and SOX2 for the ICM and CDX2 for the TE (Cockburn and Rossant, 2010) . These factors determine blastocyst lineages, but the onset of their expression is stochastic (Dietrich and Hiiragi, 2007) , and later restriction to a particular cell type occurs as a downstream effect of earlier events related to the position of blastomeres in the embryo (Rossant and Tam, 2009 ).
This process is believed to involve differences in polarity and adhesion between inner and outer cells that are related to differential activation of the Hippo signaling pathway (Hirate et al., 2013; Nishioka et al., 2009) , resulting in sustained and restricted expression of genes, such as Cdx2 in the outer cells of the future trophectoderm (Cockburn and Rossant, 2010) . Hippo signaling is switched off in outer cells, leading to nuclear localization of the transcriptional coactivator YAP, which can then activate downstream target genes through interaction with the transcription factor TEAD4. Embryos lacking Tead4 fail to develop the TE, and Cdx2 expression is not maintained (Nishioka et al., 2008; Yagi et al., 2007) . Correspondingly, overexpression of LATS2 kinase (an activator of Hippo) reduces expression of CDX2 in outer cells, whereas embryos lacking Lats1 and Lats2 express CDX2 in inner cells (Lorthongpanich et al., 2013; Nishioka et al., 2009 ). Similar results are obtained when other components of the pathway, such as Nf2 and Amot, are disrupted (Cockburn et al., 2013; Hirate et al., 2013) . How these components are integrated to fully define lineage restriction in the blastocyst is largely unknown, and additional inputs remain to be identified (Wennekamp et al., 2013) . Reconstruction of this process will require detailed understanding of the transcriptional control of the key lineage regulators acting in the preimplantation embryo.
With this aim in mind, we have searched for cis-regulatory elements responsible for trophectoderm-restricted expression of Cdx2, and through the analysis of one such enhancer, we have uncovered a role of the Notch signaling pathway. We find that Notch is active specifically in outer cells of the blastocyst. Analysis of double mutants for Tead4 and the Notch effector Rbpj shows that the Notch and Hippo pathways converge on Cdx2 to activate its expression in the trophectoderm, uncovering an unexpected role for Notch signaling during preimplantation development (Souilhol et al., 2006) . Furthermore, we show that forced activation of Notch directs blastomeres to the trophectoderm.
RESULTS

Characterization of a Trophectoderm-Specific Enhancer from Cdx2
By means of transient transgenic analysis in mouse preimplantation embryos, we identified a cis-regulatory element located 5 0 of Cdx2 that drives reporter expression in the trophectoderm (TE) of the blastocyst (Figures S1A and S1B available online). Using fragment #3 of this TE enhancer (TEE) (Figures S1A and S1B) linked to a H2B-mRFP reporter gene, we then generated several transgenic lines for further study. The reporter is only occasionally active in a few cells at the eight-cell stage ( Figure 1A ), and upon compaction, it starts to be present in the outer cells of the morula ( Figure 1B ), attaining strong activity at the 16-cell stage ( Figure 1C ). At the blastocyst stage, TEE-driven reporter activity is localized throughout the TE and excluded from the ICM ( Figure 1D ). We also generated TEE transgenic lines using a lacZ reporter, which behaved identically to the H2B-mRFP reporter lines ( Figure S1C ). Tracking blastomeres in the mRFP reporter lines up to the 3.5 dpc blastocyst revealed a steady temporal increase in the number expressing mRFP ( Figure 1E ). Reporter activity in either the mRFP or lacZ TEE lines was found throughout the TE, although occasionally we detected cells with lower levels of expression. Immunohistochemical analysis of the association between reporter activity and endogenous CDX2 showed concordant expression in >75% of blastomeres (CDX2+/TEE+, CDXÀ/TEEÀ; Figure 1F ), confirming that TEE activity closely matches the expression of CDX2 at preimplantation stages (Dietrich and Hiiragi, 2007; Strumpf et al., 2005) .
The TE Enhancer Is Active in Cdx2 and Tead4 Mutant Blastocysts We next aimed to determine the upstream regulatory factors acting on the TEE to restrict Cdx2 expression. To date, the only transcription factors proposed to regulate Cdx2 in the trophectoderm are CDX2 itself, through an autoregulatory loop (Niwa et al., 2005) , and TEAD4, acting together with YAP downstream of the Hippo pathway (Nishioka et al., 2009) . To test whether these factors are required for TEE activity in the blastocyst, we first examined homozygous Cdx2 knockout (KO) mice containing the mRFP reporter, finding that TEE reporter activity was still restricted to the TE (Figures S2A and S2B) and that the number of positive cells was the same as in wild-type (WT) littermates ( Figures S2C and S2D) .
We next analyzed the regulation of the TEE by the Hippo pathway. To check to which extent the TEE was a YAP/TEAD response element, we bred the mRFP reporter line into the Tead4 KO background (Nishioka et al., 2008) . The TEE was fully active in homozygous Tead4 À/À 3.5 dpc embryos (Figures 2A   and 2B ) and even conserved preferential activity in outer blastomeres ( Figure 2B ). Consistent with previous reports (Kaneko and DePamphilis, 2013; Nishioka et al., 2008) , we also found that some Tead4 À/À embryos retained CDX2 expression ( Figure 2C ), suggesting that additional inputs are necessary for the early expression of Cdx2. Furthermore, we did not detect significant differences in total cell number or in mRFP+ blastomeres per embryo between wild-type, heterozygous, and homozygous embryos ( Figures S2E and S2F) , precluding an effect of the loss of Tead4 on the total number of cells in which the TEE is active.
To investigate this further, we took advantage of the 5TVER7 embryonic stem (ES) cell line, which stably expresses a tamoxifen-inducible active TEAD4 protein (Tead4VP16ER) (Nishioka et al., 2009) . Upon tamoxifen induction, these cells activate Cdx2 expression and acquire a trophoblast stem (TS) cell phenotype. We transfected 5TVER7 cells with the TEE or with the Oct4 distal enhancer (Oct4DE) (Yeom et al., 1996) as a control and treated them with tamoxifen in TS culture medium (Tanaka et al., 1998) . After 48 hr in these conditions, quantitative PCR (qPCR) analysis showed robust activation of Cdx2 and downregulation of Oct4, accompanied by a strong decrease in Oct4DE activity ( Figures 2D and 2E ). Despite the forced expression of the active TEAD4 form, we did not observe a strong effect on TEE activity compared with culture in ES cell culture medium without tamoxifen, although treatment did increase its activity slightly but significantly compared with control empty vector ( Figure 2E ). These experiments provide additional evidence that TEAD4 alone is not sufficient to fully activate the TEE. We next tested if forced activation of the Hippo pathway in outer cells would silence the TEE. Embryos of the mRFP-TEE line were injected with Lats2 RNA, which turns the Hippo pathway on and results in decreased expression of CDX2 in outer cells (Nishioka et al., 2009 ). This did not influence the expression of the reporter in the TE ( Figure 2F ), confirming that the TEE does not respond exclusively to the activation state of the Hippo pathway in the blastocyst.
The Notch Signaling Pathway Is Active in the Trophectoderm of the Blastocyst To identify other transcriptional inputs acting on the TEE, we searched the minimal 1.3 kb sequence active in the TE (fragment #6; Figures S1A and S1B) for putative transcription factor binding sites; this search detected four high-confidence sites for RBPJ (Tun et al., 1994) , the transcriptional effector of the Notch pathway. RBPJ acts together with the intracellular domain of Notch, the product of the proteolytic cleavage of the receptor upon its activation that is then translocated to the nucleus (Kopan and Ilagan, 2009 ). Additionally, we detected two putative TEAD binding sites (Anbanandam et al., 2006) (Figure S3A ).
This observation suggested that Notch could have a role in development of the blastocyst, but to date there is scant evidence available for the expression of Notch pathway components at this stage (Cormier et al., 2004; Wang et al., 2004) , and no studies have addressed their differential localization. To examine the activation status of the Notch pathway during preimplantation stages, we used a mouse line containing a CBF:H2B-Venus reporter, which contains multiple RBPJ binding sites driving the expression of a nuclear-targeted Venus fluorescent protein and that faithfully reports the activation state of the 
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Role of Notch in Trophectoderm Specification pathway (Nowotschin et al., 2013) . The reporter was active in a few cells at the eight-cell stage, and activity became progressively restricted to outer cells by the 3.5 dpc blastocyst stage ( Figures 3A-3C ). Treatment of embryos from this line with the g-secretase inhibitor RO4929097 (RO), a well-characterized Figure S2 . and widely used tool that interferes with Notch signaling by blocking the processing of the receptor (Mü nch et al., 2013) , resulted in a strong downregulation of the reporter ( Figure 3D ). We next examined the distribution by immunofluorescence of the endogenous NOTCH1 intracellular domain (N1ICD), finding that it is localized to the nucleus only in the outer cells of the blastocyst (Figures 3E and S3B) . Together, these data show that the Notch signaling pathway is active specifically in the developing TE.
The TE Enhancer Contains Functional RBPJ and TEAD Binding Sites To investigate the function of the sites identified in the TEE, we transfected HEK293 cells with the wild-type minimal TEE and versions mutated in the RBPJ sites alone (TEE RBPJ mut), the TEAD sites alone (TEE TEAD mut), or in the RBPJ and the TEAD sites (TEE RBPJ/TEAD mut) ( Figure 4A ).
We then tested their response to constitutively active forms of N1ICD (Kopan et al., 1994) and TEAD4 (Tead4VP16) (Nishioka et al., 2009 ), expressed either alone or in combination. Whereas (E) Quantification of the number of TEE-positive cells (y axis) per embryo, staged by total cell number (x axis). Each dot represents an individual embryo, and the bar and whiskers indicate means and SD.
(F) Correlation of TEE activity with endogenous CDX2 protein expression at the eight-cell (n = 24; three embryos) and 16-cell stages (n = 80; five embryos). Individual blastomeres were scored for H2BmRFP and CDX2 immunostaining. See also Figure S1 .
Role of Notch in Trophectoderm Specification the wild-type TEE responded to N1ICD, the TEE RBPJ mut version did not ( Figure 4B ), demonstrating that this regulatory element is a transcriptional target of the Notch pathway. Tead4VP16 alone did not affect the wild-type TEE, consistent with the results from Figure 2E ); however, it was sufficient to transactivate the TEE RBPJ mut version ( Figure 4B ). This suggests that TEAD4 acts together with N1ICD/RBPJ to activate the TEE but cannot activate it when RBPJ is bound in the absence of N1ICD (and thus acts as a repressor [Lai, 2002] Figures 4C-4E ), whereas TEE activity was abolished when the RBPJ and TEAD sites were both mutated ( Figure 4F ). The lack of response of the TEE TEAD mut to N1ICD in vitro, while retaining activity in vivo suggests that TEAD sites are critical for enhancer activity in HEK cells, but not in the blastocyst.
5TVER7 ES cells (
To confirm the function of the identified binding sites, we combined microinjection of the mutated TEE versions for binding sites of one pathway with pharmacological disruption of the other ( Figure 4G ). To disrupt the Notch pathway, we treated microinjected embryos with RO, that as shown above blocks Notch activity in the TE ( Figure 3D ). As for the Hippo pathway, we used Verteporfin (VP), a small molecule that inhibits TEAD-YAP association (Liu-Chittenden et al., 2012) . To confirm that VP disrupts Hippo signaling as expected, we treated embryos from the mRFP reporter line and examined reporter activity together with endogenous CDX2 expression ( Figure S4A ). A high percentage of VP-treated embryos phenocopied Tead4 À/À embryos ( Figure 2B ), with strong reduction of CDX2 but TEE activity still present ( Figure S4A Figures 4H and S4C ). This shows that interfering with the transcriptional activity of YAP and TEAD4 when the TEE RBPJ sites are missing decreases enhancer activity. Taken together, these results show that transcriptional inputs from both pathways are responsible for full enhancer activity through the specific binding sites identified, acting in a redundant fashion in vivo.
Notch and Hippo Pathways Converge on Cdx2
Regulation To further explore the regulation of the TEE by Notch, we tested its activity in the absence of Notch signaling by breeding the mRFP-TEE line in the Rbpj KO background (Oka et al., 1995) . Consistent with the activity of TEE RBPJ mut in the TE ( Figure 4D ), Rbpj +/À and Rbpj À/À embryos showed normal TEE-driven expression, as is the case for Tead4 +/À embryos ( Figures 5A-5C ). These embryos also had normal numbers of cells and of TEE+ blastomeres, although Rbpj À/À embryos showed a possible but statistically nonsignificant tendency to have fewer TEE+ cells than did WT embryos ( Figure S5A ). To test for interaction between the Notch and Hippo on the TEE, we generated embryos in the mRFP-TEE line containing different combinations of Tead4 and Rbpj mutant alleles ( Figures 5D and 5E ). Double heterozygote embryos (Rbpj +/À ;Tead4 +/À ) contained significantly fewer than did normal TEE+ cells (Figures 5D and S5A) , and this effect was more marked in Rbpj
where only a few mRFP cells were detected in the TE ( Figures  5E and S5A ). This was not due to disruption of overall cell number or the inside-outside distribution of blastomeres in these embryos, as these parameters showed no significant difference compared with wild-type, Tead4 Figure S5B ). Furthermore, we observed no difference in the total number of CDX2+ cells per embryo in the different genotypes ( Figure S5B ), detecting outer blastomeres that express CDX2, but not the reporter ( Figures 5C-5E , arrowheads). Unexpectedly, we did not recover any double homozygote knockout embryos at 3.5 dpc ( Figure S5C ), suggesting that the combined lack of these two factors causes the death of embryos at an earlier stage. We next investigated whether Notch was required for endogenous levels of Cdx2 expression. Figure 5F ). The effect of Notch on Cdx2 expression was confirmed by treating embryos from the two-cell to blastocyst stages with the g-secretase inhibitor RO, which significantly decreased mRNA expression of Cdx2, but not of Oct4 or Nanog. We also examined changes in expression of other TE-expressed genes, finding that neither Gata3 nor Eomes changed significantly ( Figure 5G ), suggesting a specific requirement of Notch for Cdx2 expression. Notch on its own does not impact events downstream or parallel to Cdx2 function, what could be explained by the earlier requirement of Cdx2 as compared to Gata3 and Eomes (Ralston et al., 2010; Strumpf et al., 2005) and is consistent with Notch signaling not being strictly required for trophectoderm development (Souilhol et al., 2006) . In line with the genetic analysis, combined treatment of embryos from the mRFP-TEE transgenic line with the pharmacological disruptors of both the Notch and Hippo pathways previously used (RO+VP) strongly reduced TEE activity and endogenous CDX2 expression ( Figure S5D ). Notch signaling and RBPJ are thus necessary for proper expression of endogenous Cdx2 in the embryo, in cooperation with TEAD4. Our results thus show that the Notch and Hippo pathways act together in the preimplantation embryo, affecting TEE activity, CDX2 expression, and embryo viability.
Notch Activation Increases CDX2 Levels and Drives Blastomeres to the Trophectoderm
To further explore the role of Notch in trophectoderm development, we overexpressed the active form of NOTCH1 in the blastocyst by crossing a R26-stop-N1ICD-ires-EGFP line (Murtaugh et al., 2003) with a line carrying a maternal Sox2-Cre allele (Hayashi et al., 2003) . Most blastocysts obtained were viable (80%; n = 58), as shown by the presence of a blastocoele and proper CDX2 expression in outer cells ( Figures 6A and S6A-S6C ). Although this strategy predicts uniform recombination in all cells of the blastocyst (Figure S6G ), we found mosaic expression of the reporter at 3.5-4.0 dpc (23% EGFPÀ blastomeres; Figures  6A and 6E) . The degree of mosaicism in R26-stop-N1ICD-ires-EGFP embryos ranged from zero recombined cells to fully recombined blastocysts (Figures S6A-S6C ). This was confirmed by PCR detection of the nonrecombined allele in blastocysts obtained from this cross ( Figure S6E ), and we were also able to detect mosaic recombination using a R26-stop-YFP reporter and the maternal Sox2-Cre allele (Srinivas et al., 2001 ) ( Figures  S6F and S6H) .
We took advantage of this mosaicism to investigate whether activation of the Notch pathway could upregulate endogenous Cdx2. Quantification of CDX2 staining at the blastocyst stage showed that blastomeres overexpressing N1ICD have higher levels of CDX2 protein ( Figure 6B ). The same pattern was seen when we analyzed only outer cells (those that would normally express Cdx2) ( Figure 6C ). These results complement the earlier observation of reduced CDX2 in Rbpj mutant embryos (Figure 5F ), confirming that the Notch pathway directly regulates Cdx2 expression.
In this set of experiments, we also noticed that EGFP+ blastomeres were more often localized to the TE ( Figure 6A ), so we analyzed the spatial distribution of blastomeres overexpressing N1ICD in more detail. Whereas EGFPÀ blastomeres from mosaic embryos showed an inside-outside distribution similar to that of blastomeres from wild-type blastocysts, EGFP+ blastomeres were significantly more abundant in outside positions ( Figure 6D ). Analysis of individual blastocysts revealed that those overexpressing N1ICD had significantly more outside cells (75% versus 65% in wild-type embryos) and that EGFP+ cells were overrepresented in this population compared with inside cells (81.3% versus 64%; Figure 6E ). These results indicate that blastomeres in which the Notch pathway is active localize preferentially to the outer TE population and that cells can be directed to this population by forced overexpression of the active form of Notch1.
DISCUSSION
In this study, we have dissected the transcriptional regulation of Cdx2 in the preimplantation mouse embryo, and by characterizing an early TE-specific enhancer, we have identified Notch signaling as a component of the process. The role of Notch in cell-fate decisions during development is well established (Koch et al., 2013) , but previously no function had been described in the initial lineage choices in the early embryo, because of the fact that no loss-of-function mutant of the Notch pathway has a phenotypic effect on preimplantation development (Souilhol et al., 2006) . We find that Notch directly regulates Cdx2 expression in cooperation with TEAD4 and can also influence the fate of blastomeres by driving them to outer positions in the embryo. This cooperation is also supported by the genetic interaction of the two pathways, as no double homozygous mutants for Tead4 and Rbpj are obtained at preimplantation stages. Although other instances of interaction between Notch and Hippo have been described (Barry and Camargo, 2013; Camargo et al., 2007; Chen et al., 2011; Graves et al., 2012; Tschaharganeh et al., 2013) , the results of this study show that the Hippo and Notch pathways act in parallel and converge during the first lineage specification in the blastocyst. In this scenario, outside cells more prone to a TE fate would have the Notch pathway active and the Hippo pathway inactive. It is interesting to note that in Drosophila wing epithelial cells, inactivation of Hippo signaling results in apical accumulation of the Notch receptor (Genevet et al., 2009) .
Compound mutants for Rbpj and Tead4 show a reduction in the total number of TEE-positive cells, but not of CDX2-positive cells. However, they have below-normal expression levels per blastomeres, suggesting that additional regulatory inputs act on Cdx2 in the blastocyst. A possible mechanism is autoregulation of Cdx2 (Barros et al., 2011; Cockburn and Rossant, 2010; Niwa et al., 2005) , which would maintain and stabilize Cdx2 expression levels after initial inputs from Notch and Tead4.
Sustained activity of the Notch pathway in outer cells would ensure that they maintain a TE fate, allowing for correct specification of blastomeres that reposition during cell division. Therefore, the forced activation of the pathway we achieve by overexpressing N1ICD drives cells to relocate to the outside and adopt a TE fate. It could be argued that Notch simply elevates Cdx2 levels and that this is the trigger for cell relocation (Jedrusik et al., 2008) . However, the fact that blastomeres mutant for Cdx2 can adopt an outer position argues against this possibility (Ralston and Rossant, 2008) and suggests that Notch must target other mechanisms operating in outer cells that result in early lineage segregation.
The Notch signaling pathway's role in generating heterogeneity from an otherwise homogenous group of cells has been extensively studied (Artavanis-Tsakonas et al., 1999) . On the other hand, it has also been shown how Notch can produce local homogeneity in a tissue by signaling between adjacent cells (de la Pompa and Epstein, 2012; Lewis, 1998; Neves et al., 2011) . It would be too early to speculate which of these mechanisms, lateral inhibition or lateral induction, is involved in lineage determination in the blastocyst. Future work on how pathway components are differentially localized during preimplantation development and on the precise timing of expression of ligands and receptors will be key to resolve the role of Notch in TE specification.
The early mouse embryo has been proposed to be a self-organizing system (Wennekamp et al., 2013) , such that individual cells choose their fate according to a combination of intrinsic and extrinsic cues. In this scenario, the robustness for TE specification would be conferred through combinatorial inputs that would initiate and refine the expression of TE factors, such as Cdx2. The partially redundant activities of these inputs would be integrated via regulatory elements, such as the Cdx2 TEE, and could underlie the regulatory capacities of the mammalian embryo and the initial stochastic lineage-specific transcriptional programs.
The structure of the Cdx2 TE-enhancer described here can be used to screen for cis-regulatory elements that integrate signals from both pathways, with a similar organization of RBPJ and TEAD sites and thereby identify other components of the TE specification gene regulatory network. Future work will provide information about how modulation of Notch, together with other signaling pathways, leads to the differentiation of the totipotent cell and how symmetry is first broken during mammalian development. 
Construct Generation for Microinjection
Cdx2 genomic regions were amplified by PCR using bacterial artificial chromosome (BAC) RP245I065 as a template. This BAC covers the whole intergenic region containing mouse Cdx2 and was obtained from the BACPAC Resources Center (http://bacpac.chori.org/). The restriction enzyme strategy or primers used for PCR, together with the lengths of corresponding amplified fragments, were as follows: fragment #1, GTTTGGAGAGAAGAAAGGAG and As a positive control, we used the Pou5f1 distal enhancer element (Oct4DE) (Pernaute et al., 2010; Yeom et al., 1996) . Each fragment was subcloned in pGEM-T Easy Vector and then excised and cloned into a modified pBluescript vector (Yee and Rigby, 1993) containing either a lacZ reporter gene or H2BmRFP1 reporter gene under the control of the human beta-globin minimal promoter and including an SV40 polyadenylation signal. Constructs were linearized, and plasmid sequences were removed before microinjection.
Transient Transgenic Analysis
For the generation of transient transgenics, F1 (C57Bl/6xCBA) females were superovulated to obtain fertilized oocytes as previously described (Nagy et al., 2003) . Each construct was microinjected into the pronucleus of fertilized oocytes at E0.5 at a concentration range from 3-6 ng/ml. Microinjected oocytes were cultured in microdrops of M16 medium (Sigma) covered with mineral oil (Sigma) at 37 C, 5% CO 2 until the blastocyst stage.
A minimum of 50 blastocysts were used to calculate the percentage of lacZ or H2BmRFP-positive embryos per construct. When using the empty vector containing only the minimal promoter and the lacZ reporter as a negative control, we routinely obtained low-level punctuated lacZ expression or weak H2BmRFP expression in approximately 10% of blastocysts. For lacZ staining, blastocysts were fixed in buffer containing 1% formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl 2 , 5 mM ethyleneglycoltetraacetic acid (EGTA), and 0.02% Igepal for 5 min at room temperature. After washes in PBS, blastocysts were transferred to X-Gal staining solution for 24 hr at room temperature in the dark. For H2BmRFP detection, embryos were fixed in 4% paraformaldehyde for 10 min at room temperature and either analyzed for endogenous fluorescence or immunostaining. To visualize nuclei, embryos were incubated in DAPI at 1 mg/ml (Vector Laboratories).
Generation of TEE Mouse Lines
Three independent transgenic mouse lines where obtained for the fragment #3 TEE constructs linked to each lacZ or H2BmRFP. All lines reproduced the TErestricted expression pattern in early preimplantation stages. Genotyping was performed by PCR with primers SV40 (TCACTGCATTCTAGTTGTGG) and 5 0 -rev comp (CTGATCTTCTTCACTTCACCCAG), which generate a 150 bp product for the TEE-lacZ lines, and 5 0 Cdx2 (GCAGGTGGCTGATCTTCTTC) and mRFP (GAGCCGTACTGGAACTGAGG), which generate a 900 bp product for the TEE-H2BmRFP lines. PCR conditions were 95 C for 5 min, 35 cycles of 94 C for 1 min, 60 C for 1 min, and 72 C for 1 min, followed by 72 C for 10 min. Embryos were collected from crosses of TEE-lacZ or TEE-H2BmRFP males with outbred superovulated ICR females.
Mouse Breeding
The different mouse lines used are described in the main text. Adults were genotyped by PCR of tail-tip DNA using primers and conditions previously described for each line. For preimplantation embryos, genotyping was per- (E) Distribution per embryo of inside (gray) and outside cells (white) in wild-type (WT; n = 6) and N1ICD-overexpressing embryos (N1OE; n = 10). For N1OE embryos, the contribution of EGFPpositive cells (green) to each population is also shown. See also Figure S6 .
formed directly on individually isolated embryos, after observation in culture and X-Gal or antibody staining. Animal procedures were approved, as appropriate, by the CNIC Animal Experimentation Ethics Committee in accordance with Spanish and European regulations or by the Toronto Centre for Phenogenomics Animal Care Committee in accordance with guidelines from the Canadian Council for Animal Care.
Embryo Collection and Culture
For TEE mouse line characterization, E0.5 embryos were collected from swollen ampulas, treated with hyaluronidase (Sigma) to remove cumulus cells and cultured until the blastocyst stage at 37.5 C in 5% CO 2 in air, in M16 medium (Sigma) covered with mineral oil (Sigma). For experiments using Tead4, Cdx2, and Rbpj mutant mouse strains, E2.5 embryos were collected by flushing the oviduct through the infundibulum and were cultured up to blastocyst stage. For experiments with R26YFP and R26N1OE transgenics, E3.5 embryos were recovered by flushing uteri with M2 medium (Sigma).
Lats2 mRNA Injection
The Lats2-GFP construct was transcribed and microinjected into two-cell embryos of the TEE-H2B-mRFP mouse line as previously described (Cockburn et al., 2013) . After injection, embryos were cultured up to the blastocyst stage.
Immunohistochemistry of Preimplantation Embryos
Immunohistochemistry was performed as previously described (Dietrich and Hiiragi, 2007) . The following antibodies and dilutions were used: monoclonal mouse anti-CDX2 (MU392-UC, BioGenex) 1:200, rabbit polyclonal living colors DsRed (632496 Clontech) 1:500, rabbit polyclonal living colors GFP (632460 Clontech) 1:200, mouse anti-TEAD4 (ab58310 Abcam) 1:100, and rabbit anti-Cleaved NOTCH1 (Val1744) (2421, Cell Signaling Technology) 1:100. Cleaved NOTCH1 was also immunodetected with amplification of the signal with a tyramide amplification kit (TSA) coupled to Cy3 (1:100; PerkinElmer). Nuclei were visualized by incubating embryos in DAPI at 1 mg/ml.
Pharmacological Inhibitor Treatments
Two or four-cell embryos were cultured in drops of M16 medium (Sigma) covered with mineral oil (Sigma) at 37 C, 5% CO 2 , containing the corresponding pharmacological inhibitor or control (DMSO) until the blastocyst stage. The following inhibitors and concentrations were used: 10 mM of the g-secretase inhibitor RO4929097 (S1575, Selleckchem) (Mü nch et al., 2013) and 2.5 mM of the TEAD/YAP inhibitor Verteporfin (Sigma) (Liu-Chittenden et al., 2012) .
Cell Culture 5TVER7-ES cells were cultured on gelatin-coated dishes with 1,000 U/ml LIF (ESGRO-LIF; Millipore) as previously described (Nishioka et al., 2009 ). Tead4VP16ER was induced by incubation of cells for 48 hr with 4-hydroxytamoxifen (Sigma) at 0.1 mg/ml in EMFI-CM medium (Tanaka et al., 1998) in the presence of FGF4 (1:1,000 dilution; R&D Systems) and 1 mg/ml heparin (Sigma). Cell transfections were performed with Lipofectamine 2000 (Invitrogen) and 400 ng DNA (eGFP, empty vector, Oct4DE, or TEE), followed by growth for 48 hr.
Quantitative PCR RNA was isolated from 5TVER7 cells with the RNeasy Mini Kit (QIAGEN) and then reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). For g-secretase inhibitor experiments, RNA from pools of 25 embryos was isolated using the Arcturus PicoPure RNA Isolation Kit (Applied Biosystems) and reverse transcribed using the Quantitect Kit (QIAGEN). cDNA was used for qPCR with Power SYBR Green (Applied Biosystems) in a 7900HT Fast Real-Time PCR System (Applied Biosystems). Expression of each gene was normalized to the expression of the housekeeping genes Actin and Ywhaz (Vandesompele et al., 2002) . The following primers were used: Actin, CAGAAGGAGATTACTGCTCTGGCT (forward) and TACTCCTGCTTGCTGATCCACAT (reverse), Cdx2, TCAACCTCGCCACAACC TTCCC (forward) and TGGCTCAGCCTGGGATTGCT (reverse), Eomes, TTCACCTTCTCAGAGACACAGTTCAT (forward) and GAGTTAACCTGTCATT TTCTGAAGCC (reverse), Gata3, GGGTTCGGATGTAAGTCGAG (forward) and CCACAGTGGGGTAGAGGTTG (reverse), Nanog, CTTACAAGGGTCTG CTACTGAGATGC (forward) and TGCTTCCTGGCAAGGACCTT (reverse), Oct4, ATCAGCTTGGGCTAGAGAAGGATG (forward) and AAAGGTGTCC CTGTAGCCTCATAC (reverse), and Ywhaz, CGTTGTAGGAGCCCGTAGGT CAT (forward) and TCTGGTTGCGAAGCATTGGG (reverse).
Mutagenesis
Mutated versions of fragment #6 (TEE RBPJ mut, TEE TEAD mut, and TEE RBPJ/TEAD mut) were generated by site-directed mutagenesis (Mutagenex). RBPJ binding sites were located according to the consensus motif and changes that abolish binding were made as described (Tun et al., 1994) . TEAD binding sites were based on the MCAT consensus motif (5 0 -CATTCCA/T-3 0 ) (Anbanandam et al., 2006 (Nishioka et al., 2009 ) (100 ng). pGL3-Renilla (20 ng) was included in all cases. Twenty-four hours after transfection, firefly and Renilla luciferase activities were measured using the Dual Luciferase Assay System (Promega). Data are expressed as ratios of firefly to Renilla luciferase activities. Experiments were performed in quadruplicate. Data were normalized to the basal activity of pGL3-10xRBPJ.
Imaging and Quantification
Confocal images of microinjected or antibody-stained embryos were acquired with a Leica SP5 confocal microscope. Images were acquired with a 633 objective and 23 zoom every 2.5 mm. Images of lacZ-stained embryos were obtained with a Leica DMIRE2 inverted microscope. Images were prepared for figures using Adobe Photoshop CS5.
For quantification, unmodified images were analyzed as previously described using IMARIS imaging software (v. 7.6.3) (Bitplane) (Dietrich and Hiiragi, 2007) , with some modifications. Nuclei were segmented in 3D reconstructions based on DAPI staining with an 8 mm isosurface. After computer segmentation, segments were visually inspected and corrected when necessary. The number of nuclei staining positive for TEE, CDX2, or GFP was evaluated visually (eight-cell stage embryos) or by segmentation (IMARIS software; E2.5 to E4.5). CDX2 protein level was estimated from unmodified mean fluorescence intensities within segmented nuclei. Mean DAPI fluorescence intensity was used to minimize error caused by staining and confocal imaging variability. CDX2 intensity values for each blastomere were normalized to the mean DAPI fluorescence intensity for each nucleus, and these ratios were normalized to the average mean DAPI intensity per whole embryo.
Statistics
Statistical analyses were performed with GraphPad Prism 5. Data are presented as means ± SEM or ± SD as indicated in the figures. Differences were considered statistically significant at p < 0.05. p values were calculated by t test for comparisons of two groups and ANOVA with Bonferroni posttest for multiple pairwise comparisons. For the data presented in Figures 4H, 6D , and 6E, a chi-square test was performed. All data used for quantitative analysis are supplied in Table S1 . Scale bars, 10 μm.
